Are you looking for read ebook online? Search for your book and save it on your Kindle device, PC, phones or tablets. Download Invest in Cancer Stocks PDF full book. Access full book title Invest in Cancer Stocks by Eric Shea Broadus. Download full books in PDF and EPUB format.
Author: Eric Shea Broadus Publisher: WestBow Press ISBN: 1664287892 Category : Business & Economics Languages : en Pages : 119
Book Description
If you like investing in stocks and hate cancer, then why not build wealth by investing in companies dedicated to fighting the disease? Eric Shea Broadus, a cancer survivor and the founder of an investment advisory firm, draws on his decades of experience in the financial arena to help investors make money while supporting a great cause. Learn how to: • determine who to consult when making investment decisions; • identify publicly traded companies that are waging war against cancer; • evaluate investments based on key metrics; • establish and track investment goals. Throughout the book, the author highlights why supporting companies that are seeking to fight, treat, and cure cancer is so important, as well as the lessons he learned battling cancer. Companies dedicated to fighting cancer and bolstering the immune system are making a significant difference for millions of current and future cancer patients and have produced wonderful financial returns for many investment portfolios. Learn how to build a profitable portfolio consisting of oncology stocks, health insurance stocks, and real estate investment trusts related to cancer treatment with this guide.
Author: Eric Shea Broadus Publisher: WestBow Press ISBN: 1664287892 Category : Business & Economics Languages : en Pages : 119
Book Description
If you like investing in stocks and hate cancer, then why not build wealth by investing in companies dedicated to fighting the disease? Eric Shea Broadus, a cancer survivor and the founder of an investment advisory firm, draws on his decades of experience in the financial arena to help investors make money while supporting a great cause. Learn how to: • determine who to consult when making investment decisions; • identify publicly traded companies that are waging war against cancer; • evaluate investments based on key metrics; • establish and track investment goals. Throughout the book, the author highlights why supporting companies that are seeking to fight, treat, and cure cancer is so important, as well as the lessons he learned battling cancer. Companies dedicated to fighting cancer and bolstering the immune system are making a significant difference for millions of current and future cancer patients and have produced wonderful financial returns for many investment portfolios. Learn how to build a profitable portfolio consisting of oncology stocks, health insurance stocks, and real estate investment trusts related to cancer treatment with this guide.
Author: Joe Duarte Publisher: Prima Lifestyles ISBN: Category : Business & Economics Languages : en Pages : 424
Book Description
Medical biotechnology is a multibillion dollar global industry, and is growing rapidly. Breakout companies worldwide present highly profitable investment opportunities, but many investors avoid the sector because the science is difficult to understand and the opportunities easy to miss. Where can the layperson find reliable, fundamental information about biotechnology in order to make informed investment decisions?In Successful Biotech Investing, market expert and physician Joe Duarte, M.D., makes investing in biotech companies -- and understanding the basic science -- easy. He combines his professional medical insight and extensive financial experience to help investors easily master how to: * Interpret the science to make informed investment decisions* Analyze biotech companies for research, patents, and growth potential* Pick biotech mutual funds and indexes for maximum profit* Identify related opportunities in pharmaceutical and health-care companies* Understand the impact of the FDA and international regulations* And much moreWritten for smart investors who want to learn more about biotech and its opportun
Author: Bhavneesh Sharma, M.d. Publisher: CreateSpace ISBN: 9781517247997 Category : Languages : en Pages : 126
Book Description
The revolution in cancer treatment, especially immune-therapy (using the body's own immune system to fight cancer cells) is once in the lifetime opportunity for investors to make a fortune. This book discusses some promising cancer therapy companies with significant upside potential in stock price.
Author: Standard and Poor's Corporation Publisher: McGraw Hill Professional ISBN: 9780071384131 Category : Biotechnology industries Languages : en Pages : 336
Book Description
Standard and Poor's has been the leading brand in financial information and analysis around the world. Brokers, investment bankers, and other Wall Street professionals have relied upon S&P's unparalleled financial analysis for over 140 years. Their stock reports and ratings are among the most-respected in the industry. Now S&P's celebrated stock reports are collected for the top-rated stocks in the S&P 1500 composite index for each of today's five hottest stock sectors. Finance; Technology; Health Care, Pharmaceutical and Biotechnology; Energy; Communications and Telecom; The industries in these sectors include some of the fastest growing stocks around, and each of them include stocks assigned the prestigious 5-Star rating by S&P's top analysts. 65 percent of the 5-Star rankings allotted to stocks in S&P's 1500 composite index were assigned to stocks in one these 5 sectors! Included in each book are S&P's exclusive stock reports for the top-rated companies in each industry in the sector. Each book will also contain S&P analysts' valuable analysis of the sector as a whole and exclusive advice on how to evaluate stocks in each industry in the sector.
Author: Leo Gough Publisher: John Wiley & Sons ISBN: Category : Business & Economics Languages : en Pages : 268
Book Description
Leading investment author and journalist Leo Gough provides them with a rare insider's look at the biotech industries based on extensive interviews with industry analysts, CEOs, and leading scientists at top biotech firms, including Merck & Co., Eli Lilly & Co., Amgen Ltd., SmithKline Beecham, Inc., Genzyme Corp., Monsanto, and others."--BOOK JACKET.
Author: Les Funtleyder Publisher: McGraw Hill Professional ISBN: 0071642951 Category : Business & Economics Languages : en Pages : 304
Book Description
Is your portfolio in peak health? Ranking among the world's largest markets, the $2.5 trillion health care industry is growing at an unprecedented rate. According to Miller Tabak + Co.'s health care strategist Les Funtleyder, major structural renovations to the system are imminent. “Health care is entering an era of reform,” Funtleyder writes, “and with reform comes change and the opportunity for investment gain.” Health-Care Investing provides a thorough explanation of how the industry's mammoth size and complexity can be worked to your advantage and why health care is more resistant to changes in economic cycles than other markets. Funtleyder gives you a comprehensive overview of the industry, from both macro and micro points of view, so you can make informed decisions regarding your investments. You'll find critical information concerning The natural inelasticity of health care and how to profit from it How to take advantage of the market's complexities and inefficiencies Issues and policy changes you need to know The social responsibility aspect of investing in health care Why this market is essential for diversified portfolios In Health-Care Investing, Funtleyder provides the tools you need to dig up the richest opportunities possible and build them into your investment strategy. You'll get a detailed look at traditional market patterns and the events that have shaped--and will continue to shape--the industry. Then you'll find specific strategies you can use to maximize your profits, whether you invest in pharma, biotech, managed services, or a combination of them. This informative and practical guide also includes a list of questions you can use as an investment “template,” which will help guide your decision-making process. With Health Care Investing, you'll be armed with the know-how to make the right decisions today in order to fully capitalize on events of the future.
Author: Gene G. Marcial Publisher: FT Press ISBN: 0132703432 Category : Languages : en Pages : 224
Book Description
“Gene Marcial provides iconoclastic insights into the art of successful investing while exploding the mythology of the conventional wisdom. His 7 Commandments of Stock Investing is scintillating reading for both individual and institutional investors who seek an advantage in their moneymaking endeavors.” --Scott Black, President of Delphi Management Inc. and a member of the Barron’s Roundtable “It is well understood that trading in the stock market is full of risks. But if you are ready to take the plunge, I guarantee that there will be a time when being familiar with Gene Marcial’s 7 Commandments of Stock Investing will be extremely important. Over the years, I have followed many of the same commandments.” --Carl Icahn, Chairman, Icahn Associates “This book begins with one of the wisest investment observations I’ve ever encountered: ‘There are plenty of ways to make money in the stock market, but clinging to mainstream thinking or so-called conventional wisdom is not one of them.’ The author’s discussion on avoiding the diversification trap is alone worth many times the price of this book.” --Bernie Schaeffer, Chairman, Schaeffer’s Investment Research, Inc., www.SchaeffersResearch.com “Gene Marcial has been guiding literally millions of investors to better financial performance over his more than 30 years as a leading financial journalist. He consistently has demonstrated a rare instinct for knowing when to follow a trend and when to think like a contrarian. In today’s turbulent times, his new book, 7 Commandments of Stock Investing, is essential reading for all investors and could well add precious percentage points to the performance of any who take his words to heart.” --Stephen Leeb, President, Leeb Capital Management Inc. Every week, the investment world turns to Gene Marcial’s BusinessWeek column. Here’s why: Marcial knows how to pick winners. Apple at 15. US Steel at 19. But Marcial’s track record isn’t limited to just one or two picks. In fact, recent analysis reveals that he’s beaten the indexes for a full decade. You can’t get results like that following the “conventional wisdom”! You need to know what Gene Marcial has learned about stock investing--and this book will tell you. Marcial has distilled 35 years of experience into seven powerful, counterintuitive “commandments”: rules that are simple and practical enough for every investor to profit from. Marcial reveals why diversification is not an optimal investment strategy...why you need to focus on finding big winners, and how you can...how to profit from panic, and how to lock in your profits when everyone else is “fat and happy.” Along the way, he opens up the secret, mysterious world of corporate and market insiders--showing how to track them down, emulate their approaches, and profit from their lucrative strategies. Be prepared to profit from panic Plot a clear strategy to seize opportunities during a macro-market panic Learn how to “buy the losers” Finding tomorrow’s big winners in today’s bargain bin Profit from the unknown Finding investments that are undervalued because investors don’t understand them The “sweet seven”: specific stock picks for the next seven years What to buy right now--and hold for the long term
Author: Publisher: ISBN: Category : Languages : en Pages : 168
Book Description
For more than 30 years, Yoga Journal has been helping readers achieve the balance and well-being they seek in their everyday lives. With every issue,Yoga Journal strives to inform and empower readers to make lifestyle choices that are healthy for their bodies and minds. We are dedicated to providing in-depth, thoughtful editorial on topics such as yoga, food, nutrition, fitness, wellness, travel, and fashion and beauty.
Author: Boris Bogdan Publisher: Springer Science & Business Media ISBN: 3642108202 Category : Business & Economics Languages : en Pages : 378
Book Description
Valuation is a hot topic among life sciences professionals. There is no clear understanding on how to use the different valuation approaches and how to determine input parameters. Some do not value at all, arguing that it is not possible to get realistic and objective numbers out of it. Some claim it to be an art. In the following chapters we will provide the user with a concise val- tion manual, providing transparency and practical insight for all dealing with valuation in life sciences: project and portfolio managers, licensing executives, business developers, technology transfer managers, entrep- neurs, investors, and analysts. The purpose of the book is to explain how to apply discounted cash flow and real options valuation to life sciences p- jects, i.e. to license contracts, patents, and firms. We explain the fun- mentals and the pitfalls with case studies so that the reader is capable of performing the valuations on his own and repeat the theory in the exercises and case studies. The book is structured in five parts: In the first part, the introduction, we discuss the role of the players in the life sciences industry and their p- ticular interests. We describe why valuation is important to them, where they need it, and the current problems to it. The second part deals with the input parameters required for valuation in life sciences, i.e. success rates, costs, peak sales, and timelines.
Author: Alex Prud'homme Publisher: Harper Collins ISBN: 0061865621 Category : Business & Economics Languages : en Pages : 438
Book Description
"It began with a promising cancer drug, the brainchild of a gifted researcher, and grew into an insider trading scandal that ensnared one of America's most successful women. The story of ImClone Systems and its "miracle" cancer drug, Erbitux, is the quintessential business saga of the late 1990s. It's the story of big money and cutting-edgescience, celebrity, greed, and slipshod business practices; the story of biotech hype and hope and every kind of excess. At the center of it all stands a single, enigmatic figure named Sam Waksal. A brilliant, mercurial, and desperate-to-be-liked entrepreneur, Waksal was addicted to the trappings of wealth and fame that accrued to a darling of the stock market and the overheated atmosphere of biotech IPOs. At the height of his stardom, Waksal hobnobbed with Martha Stewart in New York and Carl Icahn in the Hamptons, hosted parties at his fabulous art-filled loft, and was a fixture in the gossip columns. He promised that Erbitux would "change oncology," and would soon be making $1 billion a year. But as Waksal partied late into the night, desperate cancer patients languished, waiting for his drug to come to market. When the FDA withheld approval of Erbitux, the charming scientist who had always stayed just one step ahead of bankruptcy panicked and desperately tried to cash in his stock before the bad news hit Wall Street. Waksal is now in jail, the first of the Enron-era white-collar criminals to be sentenced. Yet his cancer drug has proved more durable than his evanescent profits. Erbitux remains promising, the leading example of a new way to fight cancer, and patients and investors hope it will be available soon.
Author: Eric Shea Broadus
Author: Eric Shea Broadus
Author: Joe Duarte
Author: Bhavneesh Sharma, M.d.
Author: Standard and Poor's Corporation
Author: Leo Gough
Author: Les Funtleyder
Author: Gene G. Marcial
Author: 
Author: Boris Bogdan
Author: Alex Prud'homme